CYLEMBIO Trademark

Trademark Overview


On Wednesday, September 20, 2023, a trademark application was filed for CYLEMBIO with the United States Patent and Trademark Office. The USPTO has given the CYLEMBIO trademark a serial number of 79382512. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, December 17, 2024. This trademark is owned by IO Biotech ApS. The CYLEMBIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; pharmaceutical drugs and pharmaceutical substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, horm...

General Information


Serial Number79382512
Word MarkCYLEMBIO
Filing DateWednesday, September 20, 2023
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, December 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; pharmaceutical drugs and pharmaceutical substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 6, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIO Biotech ApS
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDK

Trademark Events


Event DateEvent Description
Friday, November 10, 2023APPLICATION FILING RECEIPT MAILED
Thursday, November 2, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, November 6, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 18, 2023ASSIGNED TO EXAMINER
Wednesday, December 20, 2023NON-FINAL ACTION WRITTEN
Thursday, December 21, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 2, 2024REFUSAL PROCESSED BY MPU
Tuesday, January 2, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 23, 2024REFUSAL PROCESSED BY IB
Wednesday, January 31, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 31, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 31, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 29, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, February 29, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, February 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 29, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, February 29, 2024SUSPENSION LETTER WRITTEN
Thursday, February 29, 2024LETTER OF SUSPENSION E-MAILED
Thursday, February 29, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, July 17, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, October 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 24, 2024ASSIGNED TO LIE
Wednesday, December 11, 2024APPROVED FOR PUB - PRINCIPAL REGISTER